JW Lifescience Corporation (KRX:234080)

JW Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,863	7,511	20,222	3,920	4,923	2,592
Short-Term Investments	18,932	2,110	8,126	24,953	155.05	-
Cash & Short-Term Investments	25,795	9,622	28,348	28,873	5,078	2,592
Cash Growth	-53.71%	-66.06%	-1.82%	468.59%	95.88%	-73.71%
Accounts Receivable	39,450	43,048	55,505	53,426	32,141	34,716
Other Receivables	-	16,784	252.42	346.01	257.79	161.45
Receivables	39,450	59,832	55,757	53,772	37,198	36,578
Inventory	32,955	35,448	23,399	22,067	21,077	16,786
Prepaid Expenses	-	159.78	24.78	236.47	1,044	505.8
Other Current Assets	1,454	602.96	305.56	60.7	32.79	34.08
Total Current Assets	99,655	105,664	107,834	105,008	64,430	56,496
Property, Plant & Equipment	127,558	132,051	124,577	131,555	137,145	135,423
Long-Term Investments	-	558.57	10,419	4,390	8,934	13,097
Goodwill	30,705	74,266	950.99	950.99	950.99	950.99
Other Intangible Assets	45,694	3,220	2,870	3,100	3,671	3,916
Long-Term Deferred Tax Assets	-	-	15.81	-	-	-
Long-Term Deferred Charges	206.56	248.81	305.14	484.8	689.12	893.45
Other Long-Term Assets	6,196	9,315	8,865	7,453	3,646	3,626
Total Assets	310,014	325,324	255,836	252,942	219,467	214,402
Accounts Payable	18,027	19,617	18,740	15,118	12,496	10,714
Accrued Expenses	-	1,669	1,271	1,156	724.7	655.62
Short-Term Debt	17,100	27,700	15,700	36,681	44,350	32,000
Current Portion of Long-Term Debt	30,428	8,112	30,353	336	336	2,817
Current Portion of Leases	214.15	350.82	44.91	131.02	159.77	147.67
Current Income Taxes Payable	1,331	8,594	2,739	3,645	3,279	6,200
Other Current Liabilities	15,402	14,136	25,411	22,976	22,557	16,734
Total Current Liabilities	82,501	80,179	94,259	80,044	83,902	69,268
Long-Term Debt	-	31,899	168	30,007	1,610	1,512
Long-Term Leases	1,107	1,176	46.68	40.42	31.91	60.65
Pension & Post-Retirement Benefits	4,152	4,001	-	-	-	-
Long-Term Deferred Tax Liabilities	7,218	7,406	1,828	2,011	2,243	3,305
Other Long-Term Liabilities	179.37	217.94	141.95	508.07	187.8	7,762
Total Liabilities	95,158	124,879	96,443	112,610	87,975	81,908
Common Stock	39,586	39,586	39,586	39,586	39,586	39,586
Additional Paid-In Capital	28,335	28,335	28,335	28,335	28,335	28,335
Retained Earnings	146,833	132,422	98,220	79,160	70,319	64,572
Treasury Stock	-6,749	-6,749	-6,749	-6,749	-6,749	-
Comprehensive Income & Other	6,850	6,850	0	0	0	-
Shareholders' Equity	214,856	200,445	159,393	140,332	131,492	132,494
Total Liabilities & Equity	310,014	325,324	255,836	252,942	219,467	214,402
Total Debt	48,849	69,238	46,313	67,195	46,488	36,537
Net Cash (Debt)	-23,054	-59,616	-17,965	-38,322	-41,410	-33,945
Net Cash Per Share	-1489.18	-3850.03	-1160.20	-2474.87	-2657.82	-2143.72
Filing Date Shares Outstanding	15.45	15.48	15.48	15.48	15.48	15.83
Total Common Shares Outstanding	15.45	15.48	15.48	15.48	15.48	15.83
Working Capital	17,153	25,485	13,574	24,965	-19,472	-12,772
Book Value Per Share	13909.17	12944.82	10293.69	9062.74	8491.82	8367.39
Tangible Book Value	138,457	122,959	155,573	136,281	126,870	127,627
Tangible Book Value Per Share	8963.36	7940.73	10046.95	8801.12	8193.30	8060.01
Land	41,313	41,313	32,459	32,459	32,459	32,459
Buildings	34,728	36,983	39,820	41,648	42,618	44,529
Machinery	42,937	49,269	51,450	56,836	44,976	46,086
Construction In Progress	7,271	2,987	758.47	440.73	16,903	12,143

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.